IndraLab

Statements

ATXN3 inhibits L-glutamine. 7 / 7
| 7
reach
"In contrast, full-length expanded ataxin-3 with an even longer repeat caused a much milder, selectively neurotoxic phenotype, and normal ataxin-3 actually suppressed the toxicity of other polyglutamine disease proteins."
21827905
reach
"Exogenous expression of human wild-type ataxin-3 in Drosophila suppressed polyglutamine related neurodegeneration in vivo, in a manner that was dependent on its Ub binding and chain cleaving properties [XREF_BIBR]."
21704388
reach
"In Drosophila, ataxin-3 suppresses the toxicity of expanded polyglutamine proteins in a manner that requires the catalytic activity of the Josephin domain XREF_BIBR."
21060878
reach
"Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin associated mechanism."
15808507
reach
"Strikingly, it was found that ATXN3 suppresses polyglutamine neurodegeneration in Drosophila, and this suppressing activity is dependent on its interaction with ubiquitin and on its protease activity [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
17935801
reach
"Like CHIP, ataxin-3 suppresses polyglutamine toxicity and does so in a manner linked to its ubiquitin associated activities."
21855799
reach
"Parkin can also target polyglutamine proteins ataxin-2 and ataxin-3 for ubiquitination to negatively control their levels and reduce these polyglutamine proteins induced cytotoxicity [XREF_BIBR, XREF_BIBR]."
27090516